Conditional Survival in Patients with Chronic Myeloid Leukemia in Chronic Phase in the Era of Tyrosine Kinase Inhibitors

BACKGROUND: Tyrosine kinase inhibitors (TKI) significantly improve survival in patients with chronic myeloid leukemia in chronic phase (CML-CP). Conditional probability provides survival information in patients who have already survived for a specific period of time after treatment. METHODS: Cumulat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer
Autors principals: Sasaki, Koji, Kantarjian, Hagop, Jain, Preetesh, Jabbour, Elias, Ravandi, Farhad, Konopleva, Marina, Borthakur, Gautam, Takahashi, Koichi, Pemmaraju, Naveen, Daver, Naval, Pierce, Sherry, O’Brien, Susan, Cortes, Jorge E.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4707980/
https://ncbi.nlm.nih.gov/pubmed/26479889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29745
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars